Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
(NQ:
CRBP
)
7.870
-0.270 (-3.32%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Bearish Monday For Marijuana Stocks - Maple Leaf Green World, 22nd Century Group Among Top Gainers
↗
May 05, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For May 2, 2025
↗
May 02, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From May 1, 2025
↗
May 01, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For April 28, 2025
↗
April 28, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For April 25, 2025
↗
April 25, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For April 24, 2025
↗
April 24, 2025
Via
Benzinga
Topics
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025
↗
April 23, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For April 22, 2025
↗
April 22, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For April 21, 2025
↗
April 21, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For April 18, 2025
↗
April 18, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For April 17, 2025
↗
April 17, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From April 16, 2025
↗
April 16, 2025
Via
Benzinga
Topics
Cannabis
Bearish Tuesday For Marijuana Stocks - Rocky Mountain High, Cara Therapeutics Among Top Gainers
↗
April 15, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
↗
April 11, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
↗
April 08, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For April 2, 2025
↗
April 02, 2025
Via
Benzinga
Topics
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
↗
April 01, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For March 28, 2025
↗
March 28, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For March 24, 2025
↗
March 24, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For March 18, 2025
↗
March 18, 2025
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For February 17, 2025
↗
February 17, 2025
Via
Benzinga
Topics
Cannabis
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
↗
February 14, 2025
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
↗
January 20, 2025
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For October 23, 2024
↗
October 23, 2024
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For October 21, 2024
↗
October 21, 2024
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For October 21, 2024
↗
October 21, 2024
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
↗
October 09, 2024
Via
Benzinga
Topics
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
↗
October 08, 2024
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
↗
October 04, 2024
Via
Benzinga
Topics
Cannabis
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
↗
October 04, 2024
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
